Sign in to continue:

Thursday, July 30th, 2026

Category: Hong Kong Corporate News

Hansoh Pharmaceutical Transfers Osteoarthritis Drug License to Jiangsu Hengrui for RMB131 Million

Hansoh Pharmaceutical Announces Novation and Transfer of Ost...